“Irisin Levels in Type 2 Diabetes Mellitus With and Without Non-Alcoholic Fatty Liver Disease: a Case-Control Study”. 2024. Prospects in Pharmaceutical Sciences 22 (3): 210-18. https://doi.org/10.56782/pps.254.